跳至: [中文]   [数字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 请输入前几个字:

显示项目8401-8425 / 12927. (共518页) << < 332 333 334 335 336 337 338 339 340 341 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2009-01	Nitrate in drinking water and risk of death from pancreatic cancer in Taiwan	Journal of Toxicology and Environmental Health Part A: Current Issues. 2009 Jan;72(6):397-401.
2011-05	Nitrates in drinking water and the risk of death from brain cancer: Does hardness in drinking water matter?	Journal of Toxicology and Environmental Health Part A: Current Issues. 2011 May;74(12):747-756.
2011-05	Nitrates in drinking water and the risk of death from childhood brain tumors in Taiwan	Journal of Toxicology and Environmental Health Part A: Current Issues. 2011 May;74(12):769-778.
2010	Nitrates in drinking water and the risk of death from rectal cancer: does hardness in drinking water matter?	Journal of Toxicology and Environmental Health Part A: Current Issues. 2010;73(19):1337-1347.
2009-12	Nitrates in municipal drinking water and non-hodgkin lymphoma: An ecological cancer case-control study in Taiwan	Journal of Toxicology and Environmental Health Part A: Current Issues. 2009 Dec;73(4):330-338.
2011-12	Nitrite-Mediated S-Nitrosylation of Caspase-3 prevents hypoxia-induced endothelial barrier dysfunction	Circulation Research. 2011 Dec;106(12):1375-1386.
2024-07	Nitrogen and sulfur doped carbon dots coupled cellulose nanofibers: A surface functionalized nanocellulose membranes for air filtration	Journal of the Taiwan Institute of Chemical Engineers. 2024 Jul;160:Article number 105324.
2021-04-04	Nitrogen-doped titanium dioxide mixed with calcium peroxide and methylcellulose for dental bleaching under visible light activation	International Journal of Molecular Sciences. 2021 Apr 4;22(7):Article number 3759.
2017-02	Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial	Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):2.
2017-12	Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial	Lancet. 2017 Dec;390(10111):2461-2471.
2021-07	Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab	Gastric Cancer. 2021 Jul;24(4):946-958.
2024-08-20	Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 tri	Gastric Cancer. 2024 Aug 20;Article in Press.
2020-09	Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study	Annals of Oncology. 2020 Sep;31(Suppl. 4):S1192.
2022-02	Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-contr	Lancet Oncology. 2022 Feb;23(2):234-247.
2023-11	Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome	Annals of Oncology. 2023 Nov;34(Suppl. 3):S1390.
2021-07	Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma	Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S141.
2018-09	Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials	Oncology Research and Treatment. 2018 Sep;41(Suppl. 4):285-286.
2018-02	Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials	Journal of Clinical Oncology. 2018 Feb;36(4, Suppl.):Abstract number 90.
2018-05	Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials	Journal of Clinical Oncology. 2018 May;36(15, Suppl.):Abstract number e15127.
2017-04-03	NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events	PLoS ONE. 2017 Apr 03;12(4):Article number e0174798.
2023-05-30	NMDA receptor glycine binding site modulators for prevention and treatment of ketamine use disorder	Pharmaceuticals. 2023 May 30;16(6):Article number 812.
2018-12	NNK induces miR-944 expression and modulates CISH/STAT3 signaling pathway in oral squamous cell carcinoma	Cancer Science. 2018 Dec;109(Suppl. 2):391.
2021-07-15	No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol	Scientific Reports. 2021 Jul 15;11:Article number 14567.
2007-07	No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families	Schizophrenia Research. 2007 Jul;93(1-3):391-398.
2006-05	No association of cytokine gene polymorphisms in Chinese patients with atopic dermatitis	Clinical and Experimental Dermatology. 2006 May;31(3):419-423.

显示项目8401-8425 / 12927. (共518页) << < 332 333 334 335 336 337 338 339 340 341 > >> 每页显示[10|25|50]项目